As Pfiz­er's stock surged Mon­day, Al­bert Bourla net­ted $5.6M in stock sales

On Mon­day morn­ing, Pfiz­er an­nounced they had de­vel­oped the first ef­fec­tive Covid-19 vac­cine, the world cel­e­brat­ed, their stock jumped 13% and their CEO be­came $5.6 mil­lion rich­er.

In an SEC fil­ing Tues­day, Pfiz­er CEO Al­bert Bourla dis­closed he sold off 132,508 shares at the peak of the Mon­day surge for $41.92 a piece. Bourla’s sale is kosher be­cause it was planned and pre-ap­proved in Au­gust for when the stock hit a cer­tain price, but it adds the Big Phar­ma chief to the list of ex­ec­u­tives who have drawn scruti­ny for sell­ing shares as their com­pa­ny’s Covid-19 ef­forts pro­gressed and stocks rose.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER